Toxic effects of the non-steroidal anti-inflammatory drug diclofenac

Baert, 1995, A case of diclofenac-induced colitis with focal granulomatous change, Am. J. Gastroenterol., 90, 1871 Banks, 1995, Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the food and drug administration as adverse reactions, Hepatology, 22, 820, 10.1002/hep.1840220320 Bjorkman, 1998, Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus, Am. J. Med., 105, 17S, 10.1016/S0002-9343(98)00276-9 Bort, 1999, Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity, J. Pharmacol. Exp. Ther., 288, 65 Caselli, 1995, Histological findings in gastric mucosa in patients treated with non-steroidal anti-inflammatory drugs, J. Clin. Pathol., 48, 553, 10.1136/jcp.48.6.553 Davies, 1997, Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls, Clin. Pharmacokinet., 33, 184, 10.2165/00003088-199733030-00003 Dierkes-Globisch, 2000, Asymptomatische Diclofenac-induzierte akute Hepatitis, Dtsch. Med. Wochenschr., 125, 797, 10.1055/s-2007-1024521 Dietrich, 1999, Fish embryotoxicity and teratogenicity of pharmaceuticals, detergents and pesticides regularly detected in sewage treatment plant effluents and surface waters, Toxicologist, 48, 151 EMEA, 1998. Note for guidance: Environmental Risk Assessment for Veterinary Medicinal Products other than GMO-containing and Immunological Products. EMEA, London (EMEA/CVMP/055/96). EMEA, 2003. Note for Guidance on Environmental Risk Assessment of Medicinal Products for Human Use. Draft of the European Agency for the evaluation of medicinal products (EMEA), 24 July 2003. Gut, 1996, Nichtsteroidale Antirheumatika und Azetylsalizylsäure: Nebenwirkungen distal des Duodenums, Schweiz. Med. Wochenschr., 126, 616 Hackstein, 1998, Diclofenac-assoziierte akute cholestatische Hepatitis, Z. Gastroenterol., 36, 385 Halling-Sørensen, 1998, Occurrence, fate and effects of pharmaceutical substances in the environment—a review, Chemosphere, 36, 357, 10.1016/S0045-6535(97)00354-8 Heberer, T., Stan, H.-J., 1998. Arzneimittelrückstände im aquatischen System. Wasser & Boden 50. Jahrg. 4, 20–24. Heberer, 1998, Occurrence and distribution of organic contaminants in the aquatic system in Berlin. Part I: Drug residues and other polar contaminants in Berlin surface and ground water, Acta Hydroch. Hydrob., 26, 272, 10.1002/(SICI)1521-401X(199809)26:5<272::AID-AHEH272>3.0.CO;2-O Henschel, 1997, Environmental hazard assessment of pharmaceuticals, Regul. Toxicol. Pharm., 25, 220, 10.1006/rtph.1997.1102 Kuschinsky, G., Lüllmann, H., 1981. Kurzes Lehrbuch der Pharmakologie und Toxikologie. 9. Auflage, Georg Thieme Verlag Stuttgart, New York. Landsdorp, 1990, Pharmacokinetics of retal Diclofenac and its hydroxy metabolites in man, Int. J. Clin. Pharmacol. Ther. Toxicol., 28, 298 Lehmann, M., 2000. Arzneimittel und hormonell wirksame Stoffe in Fließgewässern Baden-Württembergs. In: 25 Jahre LFU. Jahresbericht 1998/99. LFU Baden-Württemberg (Ed.). Manocha, S., Venkataraman, S., 2000. Pharmacological and histopathological evaluation of ulcer formation and end organ toxicity by NSAIDS with concurrent ranitidine treatment in aged rats. Poster presentation at the sixth Internet World Congress for Biomedical Science “INABIS 2000”. http://www.uclm.es/inabis2000/posters/files/130/index.htm. Oaks, 2004, Diclofenac residues as the cause of vulture decline in Pakistan, Nature, 427, 630, 10.1038/nature02317 Puspok, 2000, Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon, Dis. colon rect., 43, 685, 10.1007/BF02235589 Radford, 1996, Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs, JAMA, 276, 466, 10.1001/jama.276.6.466 Ramesh, 2002, A study on toxicity of diclofenac in dogs, Indian Vet. J., 79, 668 Revai, 1999, Nephrotic syndrome and acute interstitial nephritis associated with the use of diclofenac, Wien. Klin. Wochenschr., 111, 523 Romeis, B., 1989. Mikroskopische Technik. Urban und Schwarzenberg, München, Wien, pp. 390–391. Sacher, 1998, Vorkommen von Arzneimittelwirkstoffen in Oberflächengewässern, Vom. Wasser, 90, 233 Schwaiger, 1997, The use of histopathological indicators to evaluate contaminant-related stress in fish, J. Aquat. Ecosyst. Stress Recov., 6, 75, 10.1023/A:1008212000208 Stumpf, 1996, Nachweis von Arzneimittelrückständen in Kläranlagen und Fliessgewässern, Vom Wasser, 86, 291 Ternes, 1998, Occurrence of drugs in German sewage treatment plants and rivers, Wat. Res., 32, 3245, 10.1016/S0043-1354(98)00099-2 Ternes, 2001, Vorkommen von Pharmaka in Gewässern, Wasser & Boden, 53, 9 Triebskorn, R., Casper, H., Heyd, A., Eikemper, R., Köhler, H.-R., Schwaiger, J., 2004. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 68, 151–166. Webb, S.F., 2001. A data based perspective on the environmental risk assessment of human pharmaceuticals II –aquatic risk characterisation. in: Kümmerer, K. (Ed.), Pharmaceuticals in the environment. Sources, fate, effects and risks. Springer-Verlag Berlin, Heidelberg, New York, pp. 203–219. Yoon, Y., Westerhoff, P., Snyder, S., Song, R., Levine, B., 2002. A review on removal of endocrine-disrupting compounds and pharmaceuticals by drinking water treatment processes. In: Proceedings of WQTC, Seattle.